(SON) Sonoco Products - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8354951027

Tubes, Cores, Cans, Closures, Paperboard

Dividends

Dividend Yield 4.97%
Yield on Cost 5y 4.23%
Yield CAGR 5y 4.74%
Payout Consistency 77.5%
Payout Ratio 37.2%
Risk via 5d forecast
Volatility 21.4%
Value at Risk 5%th 34.8%
Relative Tail Risk -1.33%
Reward TTM
Sharpe Ratio -0.54
Alpha -24.25
CAGR/Max DD -0.21
Character TTM
Hurst Exponent 0.326
Beta 0.641
Beta Downside 0.492
Drawdowns 3y
Max DD 32.46%
Mean DD 13.76%
Median DD 12.65%

Description: SON Sonoco Products November 05, 2025

Sonoco Products Company (NYSE: SON) is a global packaging firm that designs, manufactures, and sells engineered and sustainable packaging solutions across North America, Europe, and the Asia-Pacific. Its operations are split between two segments: Consumer Packaging, which produces rigid paper containers, steel and plastic cans, and specialty closures; and Industrial Paper Packaging, which focuses on paperboard tubes, cores, and recycled paperboard products.

Key financial highlights (FY 2023) include revenue of roughly $5.3 billion, an adjusted EBITDA margin near 10 %, and free-cash-flow conversion of about 80 %. The company carries net debt at roughly 2.5 × EBITDA, indicating a moderate leverage profile relative to peers.

Sector-level drivers that materially affect SON’s outlook are the accelerating shift toward recyclable and compostable packaging-spurred by both consumer preference and tightening regulations-and the volatility of pulp and resin input costs, which can compress margins if not hedged effectively.

For a deeper quantitative view of SON’s valuation and risk profile, the ValueRay platform offers a granular breakdown of its financials and peer comparisons.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (627.8m TTM) > 0 and > 6% of Revenue (6% = 367.2m TTM)
FCFTA 0.03 (>2.0%) and ΔFCFTA -1.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -4.31% (prev 36.69%; Δ -41.00pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.06 (>3.0%) and CFO 673.1m > Net Income 627.8m (YES >=105%, WARN >=100%)
Net Debt (1.37b) to EBITDA (817.2m) ratio: 1.68 <= 3.0 (WARN <= 3.5)
Current Ratio 0.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (99.6m) change vs 12m ago 0.38% (target <= -2.0% for YES)
Gross Margin 21.46% (prev 21.25%; Δ 0.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 58.96% (prev 69.05%; Δ -10.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.43 (EBITDA TTM 817.2m / Interest Expense TTM 231.8m) >= 6 (WARN >= 3)

Altman Z'' 1.32

(A) -0.02 = (Total Current Assets 3.16b - Total Current Liabilities 3.42b) / Total Assets 11.72b
(B) 0.26 = Retained Earnings (Balance) 3.10b / Total Assets 11.72b
(C) 0.03 = EBIT TTM 330.4m / Avg Total Assets 10.38b
(D) 0.37 = Book Value of Equity 3.11b / Total Liabilities 8.40b
Total Rating: 1.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 52.44

1. Piotroski 4.50pt
2. FCF Yield 5.40%
3. FCF Margin 4.88%
4. Debt/Equity 0.49
5. Debt/Ebitda 1.68
6. ROIC - WACC (= -3.58)%
7. RoE 22.27%
8. Rev. Trend -18.75%
9. EPS Trend 0.77%

What is the price of SON shares?

As of December 14, 2025, the stock is trading at USD 42.46 with a total of 634,498 shares traded.
Over the past week, the price has changed by +2.49%, over one month by +5.39%, over three months by -9.98% and over the past year by -14.57%.

Is SON a buy, sell or hold?

Sonoco Products has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy SON.
  • Strong Buy: 5
  • Buy: 2
  • Hold: 2
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the SON price?

Issuer Target Up/Down from current
Wallstreet Target Price 53.3 25.4%
Analysts Target Price 53.3 25.4%
ValueRay Target Price 42.6 0.4%

SON Fundamental Data Overview December 02, 2025

Market Cap USD = 4.16b (4.16b USD * 1.0 USD.USD)
P/E Trailing = 22.7946
P/E Forward = 7.0274
P/S = 0.5847
P/B = 1.2586
P/EG = 0.2027
Beta = 0.544
Revenue TTM = 6.12b USD
EBIT TTM = 330.4m USD
EBITDA TTM = 817.2m USD
Long Term Debt = 3.79b USD (from longTermDebt, last quarter)
Short Term Debt = 1.37b USD (from shortTermDebt, last quarter)
Debt = 1.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.37b USD (from netDebt column, last quarter)
Enterprise Value = 5.53b USD (4.16b + Debt 1.61b - CCE 244.9m)
Interest Coverage Ratio = 1.43 (Ebit TTM 330.4m / Interest Expense TTM 231.8m)
FCF Yield = 5.40% (FCF TTM 298.4m / Enterprise Value 5.53b)
FCF Margin = 4.88% (FCF TTM 298.4m / Revenue TTM 6.12b)
Net Margin = 10.26% (Net Income TTM 627.8m / Revenue TTM 6.12b)
Gross Margin = 21.46% ((Revenue TTM 6.12b - Cost of Revenue TTM 4.81b) / Revenue TTM)
Gross Margin QoQ = 21.93% (prev 21.27%)
Tobins Q-Ratio = 0.47 (Enterprise Value 5.53b / Total Assets 11.72b)
Interest Expense / Debt = 3.80% (Interest Expense 61.2m / Debt 1.61b)
Taxrate = 5.90% (7.72m / 130.8m)
NOPAT = 310.9m (EBIT 330.4m * (1 - 5.90%))
Current Ratio = 0.92 (Total Current Assets 3.16b / Total Current Liabilities 3.42b)
Debt / Equity = 0.49 (Debt 1.61b / totalStockholderEquity, last quarter 3.32b)
Debt / EBITDA = 1.68 (Net Debt 1.37b / EBITDA 817.2m)
Debt / FCF = 4.59 (Net Debt 1.37b / FCF TTM 298.4m)
Total Stockholder Equity = 2.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.36% (Net Income 627.8m / Total Assets 11.72b)
RoE = 22.27% (Net Income TTM 627.8m / Total Stockholder Equity 2.82b)
RoCE = 5.00% (EBIT 330.4m / Capital Employed (Equity 2.82b + L.T.Debt 3.79b))
RoIC = 3.45% (NOPAT 310.9m / Invested Capital 9.00b)
WACC = 7.04% (E(4.16b)/V(5.77b) * Re(8.38%) + D(1.61b)/V(5.77b) * Rd(3.80%) * (1-Tc(0.06)))
Discount Rate = 8.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.24%
[DCF Debug] Terminal Value 78.06% ; FCFE base≈308.7m ; Y1≈329.8m ; Y5≈399.4m
Fair Price DCF = 66.42 (DCF Value 6.55b / Shares Outstanding 98.6m; 5y FCF grow 7.63% → 3.0% )
EPS Correlation: 0.77 | EPS CAGR: 22.39% | SUE: -0.67 | # QB: 0
Revenue Correlation: -18.75 | Revenue CAGR: 11.05% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.28 | Chg30d=-0.077 | Revisions Net=-4 | Analysts=8
EPS next Year (2026-12-31): EPS=6.02 | Chg30d=-0.387 | Revisions Net=-8 | Growth EPS=+6.2% | Growth Revenue=-1.5%

Additional Sources for SON Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle